Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Payables (2016 - 2025)

Cellectis (CLLS) has 6 years of Payables data on record, last reported at $21.5 million in Q4 2022.

  • For Q4 2022, Payables fell 9.7% year-over-year to $21.5 million; the TTM value through Dec 2022 reached $21.5 million, down 9.7%, while the annual FY2022 figure was $21.5 million, 9.7% down from the prior year.
  • Payables reached $21.5 million in Q4 2022 per CLLS's latest filing, down from $23.8 million in the prior quarter.
  • Across five years, Payables topped out at $24.6 million in Q4 2020 and bottomed at $15.9 million in Q4 2018.
  • Average Payables over 4 years is $21.4 million, with a median of $22.6 million recorded in 2021.
  • Peak YoY movement for Payables: soared 67.9% in 2018, then fell 9.7% in 2022.
  • A 4-year view of Payables shows it stood at $15.9 million in 2018, then skyrocketed by 54.94% to $24.6 million in 2020, then decreased by 3.44% to $23.8 million in 2021, then dropped by 9.7% to $21.5 million in 2022.
  • Per Business Quant database, its latest 3 readings for Payables were $21.5 million in Q4 2022, $23.8 million in Q4 2021, and $24.6 million in Q4 2020.